Healthcare News • Pharma Industry News Preclinical study: after heart attack, a boost in anti-inflammatory cells promoted healing 11 months ago
Healthcare News • Pharma Industry News Bayer and Puhe BioPharma enter into global license agreement for clinical phase I PRMT5 inhibitor 11 months ago
Healthcare News • Pharma Industry News Enzyme engineering opens door to novel therapies for Parkinson's, cancers and other hard-to-target protein diseases 12 months ago
Healthcare News • Pharma Industry News Scientists identify potential new genetic target for sickle cell disease treatment 12 months ago
Healthcare News • News • Pharma Industry News Gone in a Puff of Smoke? FDA’s Proposed Rule on Maximum Nicotine Levels 1 year ago
Healthcare News • News • Pharma Industry News FDA Appears to Be Granting Zombie Rare Pediatric Disease Designations Waiting for the Rare Pediatric Disease Priority Review Voucher Program to be Revived 1 year ago
Healthcare News • News • Pharma Industry News HPM’s Larry Houck Presenting at WCF Opioid and Fentanyl Abuse Management Congress 1 year ago
Healthcare News • News • Pharma Industry News Get Up To Speed on Medicare Inflation Rebates: HPM Issues Memorandum Summarizing CMS Final Rule; HPM and Riparian to Co-Host Webinar 1 year ago
Healthcare News • News • Pharma Industry News Into the Ashtray: FDA’s Previous Proposal to Ban Menthol Cigarettes 1 year ago